FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to medicine and pharmaceutical industry and describes an inhalation formulation in the form of aerosol for treating bronchial asthma and chronic obstructive pulmonary disease, containing beclomethasone dipropionate, a solvent an adjuvant and a propellant; the solvent is presented by absolute ethyl alcohol, while the adjuvant is an aerosol particle size control consisting of triethyl citrate and perfluorodecaline; the propellant is 1,1,1,4 tetrafluoroethane (HFA-134a) and/or 1,1,1,2,3,3,3-heptafluoropropane (HFA-227ea). The formulation has a higher efficacy.
EFFECT: developing the inhalation formulation in the form of aerosol for treating bronchial asthma and chronic obstructive pulmonary disease.
9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED AEROSOL PREPARATION FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2536253C1 |
| AEROSOL PREPARATION BASED ON FENOTEROL HYDROBROMIDE FOR TREATING RESPIRATORY DISEASES | 2015 |
|
RU2577289C1 |
| AEROSOL PREPARATION OF IPRATROPIUM BROMIDE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2519653C1 |
| AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2521975C1 |
| PHARMACEUTICAL COMPOSITION OF METERED AEROSOLS CONTAINING ANTIASTHMATIC AGENTS IN FORM OF SUSPENSIONS, SOLUTIONS, EMULSIONS, SOLUTIONS AND EMULSIONS | 2007 |
|
RU2356537C2 |
| METHOD AND SYSTEM FOR MDI ELECTRONIC MODEL (DOSING INHALANT DEVICE) | 2012 |
|
RU2633269C2 |
| TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
| PHARMACEUTICAL AEROSOL FORMULATIONS OF FORMOTEROL AND BECLOMETASONE DIPROPIONATE | 2010 |
|
RU2650175C2 |
| CRYSTALLINE LEVOSALBUTAMOL SULFATE, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH CONTAINS IT | 2005 |
|
RU2440972C2 |
| AEROSOL PHARMACEUTICAL COMPOSITION, A METHOD OF TREATMENT OF PATIENTS WITH RESPIRATORY DISEASES | 1992 |
|
RU2129424C1 |
